bottles labeled Insulin (Photo: Daniel Beckemeier/Shutterstock)

California is suing several companies that dominate the U.S. insulin market, accusing them of driving up prices.

“We’re going to level the playing field and make this lifesaving drug more affordable for all who need it by putting an end to big pharma’s big profit scheme,” Attorney General Rob Bonta says after filing the lawsuit last week. “These six companies are complicit in aggressively hiking the list price of insulin, at the expense of patients.”



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.